Smart cell nuclear-localising 125/131I-labelled octreotates for sandwiched β- and Auger-particle therapy of metastatic neuroendocrine tumours

Project: Research

Project Details

StatusActive
Effective start/end date1/10/202030/09/2024

Collaborative partners

Funding

  • GE Healthcare Limited: £57,343.40